
OPKO Health OPK
$ 1.15
2.68%
Quarterly report 2025-Q2
added 07-31-2025
OPKO Health Operating Cycle 2011-2026 | OPK
Annual Operating Cycle OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 285 | 298 | 111 | 56.1 | 53.5 | 97.9 | 85.2 | 93 | 103 | 217 | 219 | 254 | 474 | 446 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 474 | 53.5 | 199 |
Quarterly Operating Cycle OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 114 | 55.7 | 96 | 105 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 668 | 573 | 71.4 | 228 | 198 | 209 | 87.2 | 225 | 202 | 216 | 119 | 435 | 499 | 501 | 198 | 471 | 385 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 668 | 31.3 | 144 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
204 | $ 2.13 | -2.74 % | $ 4.89 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 25.75 | 3.0 % | $ 715 M | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 195.6 | 0.17 % | $ 21.7 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
202 | $ 65.94 | -1.51 % | $ 25.7 B | ||
|
Co-Diagnostics
CODX
|
405 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | $ 104.91 | - | $ 19.8 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.33 | 5.29 % | $ 494 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 158.0 | 2.86 % | $ 7.83 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 166.96 | 0.54 % | $ 28.7 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
315 | $ 1.46 | 26.96 % | $ 1.86 M | ||
|
Interpace Biosciences
IDXG
|
79.2 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
128 | $ 578.51 | 0.22 % | $ 46.5 B | ||
|
Agilent Technologies
A
|
161 | $ 112.02 | 0.65 % | $ 34.1 B | ||
|
Illumina
ILMN
|
198 | $ 123.79 | -0.43 % | $ 19.7 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 100.35 | 0.65 % | $ 8.28 B | ||
|
DarioHealth Corp.
DRIO
|
227 | $ 7.5 | -6.13 % | $ 29.9 M | ||
|
Guardant Health
GH
|
128 | $ 84.9 | -0.33 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.56 | 2.39 % | $ 936 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 75.73 | -0.92 % | $ 5.11 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 456.93 | 0.98 % | $ 13.2 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 264.42 | 0.54 % | $ 22 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 239.07 | 2.87 % | $ 25.5 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.66 | 1.75 % | $ 432 M | ||
|
ENDRA Life Sciences
NDRA
|
412 | $ 3.48 | 0.87 % | $ 1.87 M | ||
|
NeoGenomics
NEO
|
102 | $ 8.1 | 1.76 % | $ 1.04 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.51 | 1.1 % | $ 392 M | ||
|
Natera
NTRA
|
81.5 | $ 200.09 | 2.46 % | $ 19.7 B | ||
|
Pacific Biosciences of California
PACB
|
244 | $ 1.39 | 4.51 % | $ 417 M | ||
|
RadNet
RDNT
|
34.5 | $ 61.74 | 0.41 % | $ 4.64 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B |